Definium Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $170.0M
Liabilities Breakdown FY2022
Total Liabilities: $19.1M
Asset Breakdown
Total Assets: $170.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $142.1M | 83.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $19.9M | 11.7% |
| Intangible Assets | $3.7M | 2.2% |
| Other Assets | $4.2M | 2.5% |
Liabilities Breakdown
Total Liabilities: $19.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.1M | 11.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $17.0M | 88.9% |